vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Logistic Properties of the Americas (LPA). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $50.1M, roughly 1.7× Logistic Properties of the Americas). Logistic Properties of the Americas runs the higher net margin — 32.1% vs 22.8%, a 9.3% gap on every dollar of revenue. 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $21.4M).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Logistic Properties of the Americas is a specialized industrial real estate firm that acquires, develops and manages logistics properties across North, Central and South America. Its portfolio includes distribution centers, warehouses and last-mile delivery facilities, serving e-commerce, retail, manufacturing and third-party logistics clients.

FDMT vs LPA — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.7× larger
FDMT
$85.1M
$50.1M
LPA
Higher net margin
LPA
LPA
9.3% more per $
LPA
32.1%
22.8%
FDMT
More free cash flow
FDMT
FDMT
$7.1M more FCF
FDMT
$28.5M
$21.4M
LPA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
LPA
LPA
Revenue
$85.1M
$50.1M
Net Profit
$19.4M
$16.1M
Gross Margin
Operating Margin
17.3%
81.7%
Net Margin
22.8%
32.1%
Revenue YoY
8508900.0%
Net Profit YoY
139.1%
EPS (diluted)
$0.43
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
LPA
LPA
Q4 25
$85.1M
$50.1M
Q3 25
$90.0K
$32.7M
Q2 25
$15.0K
$21.5M
Q1 25
$14.0K
$10.5M
Q4 24
$1.0K
Q3 24
$3.0K
$19.2M
Q2 24
$5.0K
Q1 24
$28.0K
$9.2M
Net Profit
FDMT
FDMT
LPA
LPA
Q4 25
$19.4M
$16.1M
Q3 25
$-56.9M
Q2 25
$-54.7M
Q1 25
$-48.0M
Q4 24
Q3 24
$-43.8M
Q2 24
$-35.0M
Q1 24
$-32.4M
Operating Margin
FDMT
FDMT
LPA
LPA
Q4 25
17.3%
81.7%
Q3 25
-67983.3%
Q2 25
-396373.3%
Q1 25
-383007.1%
Q4 24
Q3 24
-1704400.0%
Q2 24
-849120.0%
Q1 24
-136200.0%
Net Margin
FDMT
FDMT
LPA
LPA
Q4 25
22.8%
32.1%
Q3 25
-63195.6%
Q2 25
-364386.7%
Q1 25
-342657.1%
Q4 24
Q3 24
-1461433.3%
Q2 24
-699060.0%
Q1 24
-115717.9%
EPS (diluted)
FDMT
FDMT
LPA
LPA
Q4 25
$0.43
$0.33
Q3 25
$-1.01
$0.09
Q2 25
$-0.98
$-0.06
Q1 25
$-0.86
Q4 24
Q3 24
$-0.79
$-1.26
Q2 24
$-0.63
Q1 24
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
LPA
LPA
Cash + ST InvestmentsLiquidity on hand
$402.7M
$27.3M
Total DebtLower is stronger
$296.8M
Stockholders' EquityBook value
$505.7M
$324.6M
Total Assets
$566.7M
$700.8M
Debt / EquityLower = less leverage
0.91×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
LPA
LPA
Q4 25
$402.7M
$27.3M
Q3 25
$305.1M
Q2 25
$293.2M
Q1 25
$321.4M
Q4 24
$424.9M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
$1.1M
Total Debt
FDMT
FDMT
LPA
LPA
Q4 25
$296.8M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FDMT
FDMT
LPA
LPA
Q4 25
$505.7M
$324.6M
Q3 25
$369.0M
Q2 25
$420.9M
Q1 25
$469.7M
Q4 24
$510.6M
Q3 24
$552.9M
Q2 24
$588.3M
Q1 24
$600.6M
Total Assets
FDMT
FDMT
LPA
LPA
Q4 25
$566.7M
$700.8M
Q3 25
$424.0M
Q2 25
$473.6M
Q1 25
$515.7M
Q4 24
$560.4M
Q3 24
$604.0M
Q2 24
$620.1M
Q1 24
$629.9M
Debt / Equity
FDMT
FDMT
LPA
LPA
Q4 25
0.91×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
LPA
LPA
Operating Cash FlowLast quarter
$28.6M
$21.6M
Free Cash FlowOCF − Capex
$28.5M
$21.4M
FCF MarginFCF / Revenue
33.5%
42.7%
Capex IntensityCapex / Revenue
0.1%
0.3%
Cash ConversionOCF / Net Profit
1.47×
1.34×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$12.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
LPA
LPA
Q4 25
$28.6M
$21.6M
Q3 25
$-46.5M
$14.4M
Q2 25
$-43.4M
$7.2M
Q1 25
$-47.8M
$4.4M
Q4 24
$-134.6M
Q3 24
$-29.4M
$8.3M
Q2 24
$-30.2M
Q1 24
$-29.1M
$4.8M
Free Cash Flow
FDMT
FDMT
LPA
LPA
Q4 25
$28.5M
$21.4M
Q3 25
$-46.6M
$-7.3M
Q2 25
$-43.4M
$-3.1M
Q1 25
$-48.4M
$966.4K
Q4 24
$-138.4M
Q3 24
$-31.2M
$-2.4M
Q2 24
$-30.6M
Q1 24
$-29.8M
$218.9K
FCF Margin
FDMT
FDMT
LPA
LPA
Q4 25
33.5%
42.7%
Q3 25
-51765.6%
-22.2%
Q2 25
-289620.0%
-14.4%
Q1 25
-345635.7%
9.2%
Q4 24
-13837100.0%
Q3 24
-1038966.7%
-12.3%
Q2 24
-611840.0%
Q1 24
-106421.4%
2.4%
Capex Intensity
FDMT
FDMT
LPA
LPA
Q4 25
0.1%
0.3%
Q3 25
101.1%
66.1%
Q2 25
440.0%
47.9%
Q1 25
4507.1%
32.5%
Q4 24
378600.0%
Q3 24
59266.7%
55.5%
Q2 24
6980.0%
Q1 24
2535.7%
50.0%
Cash Conversion
FDMT
FDMT
LPA
LPA
Q4 25
1.47×
1.34×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons